Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nazilai granules for common cold (热性乃孜来)
CTR20230253Phase 2Completed
- Sponsor
- Xinjiang Institute of Ecology and Geography
- Start
- Jan 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Nazilai in nasopharyngitis, sponsored by Xinjiang Institute of Ecology and Geography. Started Jan 2023; status: completed.
02
Drugs
Nazilai
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20230253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230253.